Form DEFC14A - Definitive proxy statement, contested solicitations:
SEC Accession No. 0000849146-23-000146
Filing Date
2023-09-22
Accepted
2023-09-21 18:03:19
Documents
7

Document Format Files

Seq Description Document Type Size
1 DEFC14A lfvnproxystatementfy2024-f.htm DEFC14A 1391574
2 imagea.jpg GRAPHIC 58047
3 lfvnuniversalproxycardupda.jpg GRAPHIC 577508
4 lfvnuniversalproxycardupdaa.jpg GRAPHIC 157706
5 morrowsodali.jpg GRAPHIC 25557
6 morrowsodali1.jpg GRAPHIC 4637
7 tsr.jpg GRAPHIC 46570
  Complete submission text file 0000849146-23-000146.txt   2586488
Mailing Address 3300 TRIUMPH BLVD SUITE 700 LEHI UT 84043
Business Address 3300 TRIUMPH BLVD SUITE 700 LEHI UT 84043 801-432-9000
Lifevantage Corp (Filed by) CIK: 0000849146 (see all company filings)

EIN.: 900224471 | Fiscal Year End: 0630
Type: DEFC14A
SIC: 2834 Pharmaceutical Preparations

Mailing Address 3300 TRIUMPH BLVD SUITE 700 LEHI UT 84043
Business Address 3300 TRIUMPH BLVD SUITE 700 LEHI UT 84043 801-432-9000
Lifevantage Corp (Subject) CIK: 0000849146 (see all company filings)

EIN.: 900224471 | Fiscal Year End: 0630
Type: DEFC14A | Act: 34 | File No.: 001-35647 | Film No.: 231269927
SIC: 2834 Pharmaceutical Preparations